Krishna Padmanabhan

Vice President, Innovative Statistical Consulting

Krishna Padmanabhan has nearly 20 years of experience as a statistician and a drug developer in the pharmaceutical industry. He has expertise in end-to-end drug development acquired through varied roles within R&D and Commercial functions at Wyeth Pharmaceuticals, followed by Pfizer.

Krishna’s experiences span a variety of therapeutic areas across the Specialty Care space, with a special emphasis on Rare Diseases, Oncology, Neuroscience, Anti-Infectives and Endocrine care diseases.

Krishna is also an adjunct faculty member at the University of Pennsylvania where he teaches Probability, Statistics and Machine Learning.